直接心脏压缩装置的过去,现在和有前途的未来
Melanie P Hager1, Paulamy Ganguly2, George V Letsou3
1Texas A and M University, Department of Biomedical Engineering, College Station, Texas, USA; Texas A and M University, School of Medicine, Bryan, Texas, USA.
JACC. Basic to translational science
|July 31, 2025
概括
直接心脏压缩 (DCC) 设备通过避免血液接触和血管访问,提供机械心脏支持 (MCS) 的优势. 最近的进展表明,心脏表现得到改善,损伤最小,为临床试验铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 医疗器械 医疗器械
背景情况:
- 目前的机械心脏支持 (MCS) 设备涉及血液接触,导致血栓形成和中风等并发症.
- 现有的MCS通常需要血管接入,造成出血和四肢缺血的风险.
- 直接心脏压缩 (DCC) 装置代表了一种新的MCS方法,旨在减轻这些问题.
研究的目的:
- 审查直接心脏压缩 (DCC) 设备的发展和进步.
- 为评估即将进行的临床试验提供对DCC技术的全面理解.
- 突出DCC相对于现有的机械心脏支持系统的优势.
主要方法:
- 在过去几十年中,对DCC设备的技术进步进行了审查.
- 对心脏表现和组织影响报告的改善的分析.
- 对DCC设备的临床试验状态的总结.
主要成果:
- DCC设备避免直接与血液接触,消除了相关的血液学并发症和抗凝血需求.
- DCC消除了血管接入的需要,降低了出血和缺血的风险.
- 显著的技术进步已经导致DCC设备改善心脏功能和最小的组织损伤.
结论:
- 直接心脏压缩 (DCC) 装置为机械心脏支持提供了一个有希望的替代方案.
- DCC技术的进步已经解决了当前MCS的局限性,设备进入临床试验.
- 随着人类试验的开始,对DCC的进一步理解和评估至关重要.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
Cardiac Catheterization I: Pre-Procedure Overview
160
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
160
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52


